跳至主要内容
临床试验/CTRI/2023/10/058835
CTRI/2023/10/058835尚未招募2 期

A comparative study to evaluate the effect of pyridoxine supplementation on neuropsychiatric adverse effects in persons with epilepsy on Levetiracetam therapy versus Brivaracetam-A randomized double blind, placebo controlled study. - NI

AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age more than or equal to 18 years.
  • 2.Persons diagnosed with epilepsy on the basis of ILAE definition on Levetiracetam monotherapy(for not more than 3 months or newly prescribed).
  • 3.Persons diagnosed with epilepsy on the basis of ILAE definition on Brivaracetam monotherapy(for not more than 3 months or newly prescribed).
  • 4.Subjects willing to participate and able to provide written informed consent.

排除标准

  • 1.persons who are unwilling to participate and do not provide written informed consent.
  • 2.Persons who consume alcohol.
  • 3.Pregnant and lactating women.
  • 4.Persons with current or past diagnosis of mental illness or treatment related to the same.
  • 5.Persons with uncontrolled hypertension, unstable heart disease or known case of myocardial infarction.
  • 6.Persons with concurrent hepatic, renal or pulmonary dysfunction .
  • 7.Persons with a current or past diagnosis of malignancy.

研究者

发起方
AIIMS New Delhi

相似试验